Ustekinumab for Crohn’s disease: a nationwide real-life cohort study from Finland (FINUSTE)

Anja Eberl, Taru Hallinen, Clas-Göran af Björkesten, Markku Heikkinen, Eija Hirsi, Mikko Kellokumpu, Inka Koskinen, Veikko Moilanen, Christian Nielsen, Heikki Nuutinen, Ulla-Maija Suhonen, Karri Utriainen, Ilkka Vihriälä, Erkki Soini, Christina Wennerström, Riikka Nissinen, Andras Borsi, Minni Koivunen, Jyrki Tillonen, Taina Sipponen

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalScandinavian Journal of Gastroenterology
Pages (from-to)718-725
Number of pages8
ISSN0036-5521
DOIs
Publication statusPublished - 11 Jun 2019
MoE publication typeA1 Journal article-refereed

Fields of Science

  • 3121 Internal medicine
  • Crohn's disease
  • biomarkers
  • biologics
  • inflammatory bowel disease
  • IL-12
  • 23
  • ustekinumab
  • endoscopic remission
  • MAINTENANCE THERAPY
  • WORLD EXPERIENCE
  • INDUCTION
  • SAFETY

Cite this